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                       Periodontal medicine, as  suggested by Offenbacher , as  a broad term that 
defines a rapidly emerging branch of periodontology focusing on the wealth of new data 
establishing a strong relationship between periodontal health or disease and systemic 
health or disease. It means a two-way relationship in which periodontal disease in an 
individual may be a powerful influence on an individual’s systemic health or disease as 
well as the more customarily understood role that systemic disease may have influence 
on individual’s periodontal health or disease 1 . 
                 There are various modern pathogenic concepts for systemic disorders, which 
includes like auto intoxification, focal infection, psychosomatic disease, and 
autoimmunity. “Focal infection theory” was given by Miller, speak about the role of 
various oral pathogens in the systemic disease. There has been significant progress in 
validating the plausibility of oral disease disseminating to cause systemic diseases. 
Various studies have shown a substantial relation between poor oral hygiene to increased 
susceptibility for various systemic disorders. The field of periodontal medicine has 
evolved into a significant oral and systemic health care media, since its inception in 1996 
during the world workshop in Periodontics 2 .  
                      Periodontal disease is an inflammatory process, they affect the protective 
and supportive tissues found around the tooth. Bacterial plaque accumulation found on 
the tooth surface leads to the marginal tissue inflammation, known as gingivitis. When 
gingivitis is left untreated, it may progress to periodontitis, which is characterized by loss 
of periodontal attachment support 3.        
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                     Periodontal disease during pregnancy could be a risk factor for adverse 
pregnancy outcomes such as preterm birth. Women with the active periodontal disease 
during pregnancy might experience translocation of periopathogenic bacteria to the 
uteroplacental unit, which ultimately damages the placenta. Obesity has been suggested 
to be associated with periodontitis. Pre-pregnancy obesity could be an important and 
potentially modifiable source of preterm birth (PTB). Obese women are likely to have a 
higher risk for pregnancy outcomes. Because obesity has effects on metabolic and 
immune parameters, it may increase the host’s susceptibility to periodontal disease. This 
association could be identified more clearly in pregnant women as pregnancy increases 
the host’s susceptibility to systemic inflammation caused by pregnancy related hormonal 
influences on the immune system . Considering the abundance of evidence supporting the 
association among obesity, periodontitis, and PTB, it can be inferred that obesity and 
periodontitis before or during pregnancy have synergistic effects on PTB 4. 
                       Preterm birth  is  the leading perinatal problems worldwide and has evident 
public health implications because it is closely related to perinatal mortality and 
morbidity. Multiple factors, some of which are preventable, have been associated with 
PTB , e.g., alcohol, smoking or drug use during pregnancy, high or low maternal age, low 
socioeconomic status, reduced prenatal care, low maternal body mass index (BMI), 
hypertension, generalized infections, genitourinary tract infections, cervical 
incompetence, diabetes, nutritional status, stress and multiple pregnancies. Increasing 
efforts have been made to diminish the effects of these risk factors by preventive 
interventions during prenatal care 5. 
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                        In 1891, Miller published the theory of “focal infection” which 
hypothesized that oral foci of infection were responsible for a number of regional and 
systemic diseases, such as tonsillitis, pneumonia, endocarditis and septicemia. However, 
the lack of scientific evidence condemned this theory to dormancy. In 1990s, 
Offenbacher’s group studied about a bacteremia and “chamber” model to mimic a focal 
infection on pregnant hamsters found that periodontal bacteria and inflammatory 
mediators have the ability to disseminate systematically to the foetal-placental unit, via 
the blood circulation and which induces the pregnancy complications and they proposed 
oral infection, such as periodontitis, act as a distant infectious reservoir and affects the  
pregnancy outcome. During pregnancy, due to physiological hormonal changes, there is a 
systematic inclination of risk to periodontal disease. 
                       A large number of studies associate an increase in the levels of local and 
systemic markers of inflammation with adverse pregnancy outcomes. Hence, the elevated 
levels of  Interleukin-1β, Interleukin -α, Tumor Necrosis Factor -α , Prostaglandins E2, 
Fibronectin and α-Foetoprotein in the amniotic fluid have been associated with Preterm 
Birth , while other biomarkers such as MMPs, estriol, elastase, protease, phospholipase, 
prolactin, myeloperoxidase and tissue inhibitor of MMP (TIMP)-1 have been evaluated 
but with inconclusive results. Maternal serum increased with the levels of pro-
inflammatory cytokines, such as IL-1, IL-6, IL-8 and TNF-α, has also been shown to be 
associated with prematurity or low birth weight. 4 C-reactive protein (CRP), is an acute 
phase reactant synthesized by the liver in response to pro-inflammatory cytokines, and 
are implicated as marker of systemic inflammation found to be associated with PTB. 
Besides PTB, elevated levels of CRP have been shown to be associated with an increased 
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risk for other pregnancy complications, such as intrauterine growth restriction (IUGR) 
and pre-eclampsia 6. 
                       CRP increases the inflammatory response through complement activation, 
tissue damage, and induces the inflammatory cytokines and may mediate relationship 
between periodontitis and adverse pregnancy outcomes 7. The presence of the biomarker 
CRP in saliva provides an opportunity for development of novel approaches for 
noninvasive assessment of inflammation 8. 
                      The most of the physiological and hormonal changes in the life of a woman 
occurs during the pregnancy, and among that oral cavity is one of the targeted area 
involved by this changes. All functions of the mother’s host should adapt to the new 
condition. Although other hormonal changes also found to occur, the most hormonal 
change is the increased production of estrogens and progesterone. The production of 
these hormones which gradually increases during the  pregnancy until the 8th month. 
During the period of last month of the pregnancy, progesterone concentrations found to 
be remain relatively constant, whereas estrogen levels found to continue to rise. The 
reason for the increased production of hormones during pregnancy is mainly due to the 
placenta, which is involved over the production of progesterone and estrogens in early 
period of the pregnancy time , which is the the main source of these hormones from the 
2nd trimester to term. Estrogen levels are found to rise more than 100-fold from the 
beginning period of pregnancy. Progesterone concentrations found to rise even more. The 
estrogen to progesterone ratio in the blood changes from 100:1 in early pregnancy to 
nearly it becomes 1:1 at term. During labor, when the placenta is withdrawn, there is 
marked fall occurs in both the progesterone and estrogens levels. Within 2–3 days of 
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delivery, the hormone concentrations will reaches their non-pregnant levels 9.  Maternal 
health has long been recognized as an important determinant in reducing the risk for 
pregnancy-related complications such as preterm birth and pre-eclampsia. The oral 
changes that can occur in pregnancy have been followed with focus of interest for many 
years. Physiological changes which occur in pregnant women adversely affect oral health 
status. Increase in the level of estrogen and progesterone enhances the inflammatory 
response and consequently brings changes in the gingival tissue. During pregnancy, the 
incidences of gingivitis and periodontitis are increased, and many pregnant women suffer 
from bleeding and swollen gums. Periodontal disease is a persistent bacterial infection, 
leads to a chronic and systemic challenge with the bacterial substances and host-derived 
inflammatory mediators that are capable of initiating and promoting systemic diseases. 
According to Lieff et al., 2004, adequate oral hygiene habits were mandatory to control 
the development of periopathogenic oral biofilms, which have been reported to be 
associated with poor obstetric outcomes 10. Even though there exists in a controversy 
regarding the role of oral health as an independent contributor to abnormal pregnancy 
outcomes, the recognition and understanding of the importance of oral health has led to 
significant research into the role of maternal oral health in pregnancy outcomes 11. 
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AIM : 
The aim of the present study is to estimate the level of salivary c reactive protein in 
pregnant women with obesity and periodontitis and to identify their potential risk for 
preterm birth. 
 
OBJECTIVES : 
 To estimate the salivary c reactive protein in pregnant women and their 
correlation with preterm birth. 
 To correlate the association between obesity, periodontitis and preterm birth. 
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                                                 GENERAL REVIEW 
                      According to sir William Osler (1875) mouth is the mirror and gateway 
of the body, which reflects manifestations of other systemic diseases. Pregnancy 
represents a feto-maternal balance between the tumor like acquirement of the growing 
fetus and the maternal immune system that has the potential to reject the developing 
fetus. The placenta functions as a physiological buffer between the mother and the 
fetus to suppress maternal immune surveillance and to simultaneously exchange the 
nutrients and waste products needed for fetal growth. Maternal hormones, such as 
progesterone induce a relative state of mild immune tolerance to prevent rejection of 
the semi allogenic fetal graft, but the cellular and molecular inflammatory mechanism 
of rejection would remain intact. If this inflammatory process is regulated and 
selectively activated, it can provide an efficient mechanism for inducing delivery. The 
fact is that intra amniotic levels of many inflammatory mediators, such as PGE2 
increase during pregnancy and peak at delivery suggests that these mechanisms play 
an important role in normal physiologic parturition. Furthermore, if maternal infection 
threatens the fetus and the mother, then these mechanisms need to be functional as a 
safe guard to induce abortion to assure the survival of the mother. Thus, the maternal 
inflammatory response can be regarded as the effector arm of the immune response, 
which can be carefully orchestrated to regulate tissue responses leading to delivery, 
especially coordinating changes in cervical tone, membrane integrity, and uterine 
contraction. Thus, this common effector pathway of inflammation comes to bear in 
both normal physiologic parturition and under circumstances of pathology, especially 
when associated with early cervical dilation and effacement, preterm rupture of 
membranes, and premature uterine contraction 12.
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FIGURE 1 : RELATIONSHIP BETWEEN PERIODONTITIS AND PRETERM 
BIRTH 
 
                      Periodontitis is caused by a chronic, anaerobic gram-negative infection, but 
the severity of the disease appears to be principally driven by the magnitude of the host 
inflammatory response 13. Bacterial Vaginosis (BV) is also a common infectious cause of 
preterm deliveries; however the maternal inflammatory response is the effector 
mechanism that leads to prematurity 14,15. Recent data 16 suggest that more severe 
periodontal disease was found in PLBW mothers as compared to normal birth weight 
(NBW) mothers, even after adjusting for several known factors.  
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 The possibility that periodontal gram negative infections may be important 
with respect to preterm birth has come from a study 17 in which periodontal disease was 
shown to be a significant risk for preterm birth. The condition of increased gingival 
inflammation during pregnancy 18 has been known for many years. In fact, there have 
been suggestions that it may be related to immunosuppression in the second trimester. 
The infected periodontium can also be regarded as a reservoir for both microbial 
products and inflammatory mediators.  
ASSOCIATION BETWEEN INFECTION AND PRETERM LOW BIRTH 
WEIGHT : 
                    Several studies 19, 20, 21, 22, 23, 24 had demonstrated that there were association 
between infection and PLBW. The first evidence regarding this association was  involved 
in the increased prevalence rate of maternal lower genitourinary tract infections with 
pregnancy complications such as PTL (Pre Term Labor) and LBW (Low Birth Weight). 
Rates of this preterm delivery were 1.5 to 2.3 time’s normal than those have been found 
among the women with group B Streptococci bacteriuria. Gram negative Bacteroides 
species also been investigated to find their association with preterm delivery and 
premature rupture of membrane. One study 22 showed that 40% increase in preterm 
delivery rates in mothers who were found to colonized with cervical Bacteroides at their 
initial prenatal visits. Vaginal Bacteroides colonization was found to be associated with 
60% increased risk of preterm delivery.  
Furthermore, genitourinary tract infection also found to be associated with the 
LBW, without infection of the fetal placental unit. These observations have supported the 
current opinion that preterm LBW that occurs as a result of infection is mediated 
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indirectly, mainly by the translocation of bacterial products such as endotoxin 
(lipopolysaccharides, LPS) and also by the action of maternally produced inflammatory 
mediators. TNF -α level also shown to be increased in periodontal disease conditions. 
 
FIGURE 2: ROLE OF INFLAMMATORY MEDIATORS ON PRETERM LABOR 
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Cellular and biochemicalmechanisms involved in the initiation of preterm 
labor in case of intrauterine infection 
(B = bacteria; 
M = monocyte / macrophage; Dc = decidua; 
IL1 = interleukin – 1; 
TNF = tumor necrosis factor / cachectin; 
PG = prostaglandin; 
PAF = platelet activating factor). 
 
 
                   The inflammation and intra amniotic link about levels of cytokines has been 
recently examined in a study 25 conducted at the University of North Carolina. In 
investigation about the levels of PGE2 and IL-1 present within the gingival crevicular 
fluid (GCF) of 18 women in sample of early mid-trimester were compared to the levels 
of these mediators in amniotic fluid. The study demonstrated that the GCF levels of 
PGE2 and IL-l were highly correlated with the levels of intra amniotic PGE2 and IL-l, 
and it appears that the GCF levels may eventually be used as a diagnostic test to provide 
an indirect estimate of the amniotic fluid levels of PGE2 , appropriate studies were 
conducted to establish about sensitivity and specificity. This may provide information 
about the possible screening of expectant mothers by measuring GCF levels of PGE2 
and IL-l , which are known amniotic factors associated with PLBW. It is a far less 
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invasive procedure when compared to amniocentesis and has a reduced risk of affecting 
the developing fetus. 
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RELATIONSHIP BETWEEN PERIODONTITIS AND OBESITY: 
T.Saito et al (2001) 26, studied the relationship between upper body obesity and 
periodontitis. They did the study among 643 apparently healthy, dentulous Japanese 
adults. Waist-hip ratio, body-mass index (BMI), and body fat were considered as 
significant risk indicators for periodontitis. Subjects were divided into four BMI 
categories. In only the subjects with high waist-hip ratio, higher categories of BMI  
significantly increased the adjusted risk of periodontitis, when compared with the  
subjects with low waist-hip ratios and the lowest category of BMI.  
Jorge A. Zermeño-Ibarra et al (2010) 27 conducted a cross sectional study to know 
about the relationship between overweight-obesity and periodontal disease in Mexico 
individuals. They found that periodontal disease showed statistically significant 
differences in the group of subjects with overweight-obesity.  
Saxlin T et al (2010) 28 performed a longitudinal study to investigate the association 
between the body weight and periodontal infection. He concluded that this longitudinal 
study does not provide any evidence that overweight and obesity can be considered as 
significant risk factors in the pathogenesis of periodontal infection.  
Chaffee BW et al. (2010) 29 done a systematic review of 70 cross sectional studies, 
suggested that 41 studies showed positive association between chronic periodontal 
disease and obesity. Also positive association between periodontal disease and obesity 
was suggested across diverse populations. The prevalence of periodontal disease is likely 
to be higher among obese patients, although there was no current evidence to recommend 
differences in treatment planning. 
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Singh MP et al. ( 2013) 30  did a study to evaluate the relationship between obesity and 
periodontitis and showed that the prevalence of periodontitis were significantly more in 
obese patients than in non obese. They concluded that strong correlation exists between 
obesity& periodontitis. Obese with high serum triglycerides & LDL could be at higher 
risk of periodontitis.  
Palle AR et al. (2013) 31 demonstrated significant association between measures of 
overall and abdominal obesity (BMI and WC) and periodontal disease showed significant 
association in their cross sectional study.  
Giri DK et al. (2013) 32 did a study to determine the association of obesity with 
periodontal disease in a semi urban Indian population. No association was obtained 
between BMI and periodontitis. Hence it was concluded, that good oral hygiene and 
normal body weight can reduce the overall inflammatory burden, thereby reducing the 
risk for development of periodontal disease.  
L. Scorzetti et al (2013) 33 studied the relationship between the obesity and periodontal 
disease in children. The study showed an association between obesity and periodontal 
risk indicators in children that in the long term may lead to oral conditions. And they 
concluded that the oral health of overweight/obese subjects should be more carefully 
supervised and checked in order to prevent oral alterations. 
Jelena Prpic et al (2013) 34 studied the relationship between the association of obesity 
with periodontitis, tooth loss and oral hygiene in non-smoking adults. They concluded 
that obesity was associated with tooth loss, oral hygiene, and education level in the 
investigated group and the study showed that BMI could not be correlated with severity 
of periodontal disease, except in poorly educated women aged 36–55 years. 
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Shashikanth Hegde et al (2014) 35 conducted a pilot study to know the role of obesity 
and chronic periodontitis . A total of 20 systemically healthy patients, aged 30 to 60 years 
were included in the study.  Gingival index was significant in obese group with chronic 
periodontitis compared to non obese group with chronic periodontitis. This pilot study 
had shown the  significant differences in gingival index, waist circumference, body mass 
index, total cholesterol, triglycerides and LDL levels, between obese and non obese 
group. The probing depth and loss of attachment were higher in the obese group, when 
compared to the non obese group. 
Amelie keller et al (2015) 36 analysed among eight longitudinal and five intervention 
studies and suggested that overweight, obesity, weight gain, and increased waist 
circumference may act as a risk factors for the development of periodontitis or results in 
worsening of periodontal measures. 
Sania et al (2017) 37 reviewed about the relationship between obesity and periodontitis 
concluded that this relationship needs further investigation, periodontists should counsel 
obese persons regarding the possible oral complications of obesity, to diminish the future 
risk of occurrence for these individuals. 
Jiabao Sun BA et al. (2017) 38 analyzed and done literature search  that obesity and 
periodontal disease can exert similar pathogenic effects via common pathways, and can 
influence each other bidirectionally. Elucidating about the relationship between obesity 
and periodontal disease  allows for the development of care guidelines and 
recommendations for clinicians and the public. 
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RELATIONSHIP BETWEEN PERIODONTITIS AND ADVERSE OUTCOMES 
DURING PREGNANCY: 
S.Offenbacher et al (2001) 39 conducted a 5 year prospective study designed to 
determine whether maternal periodontal disease contributes to the risk of prematurity and 
growth restriction in presence of tradional obstetric risk factors . The findings indicate 
that periodontal disease incidence or progression has a significant effect on birth weight 
and maternal periodontal infection affects fetal growth. 
Juha Oittinen et al (2005) 40 studied clinically about Periodontal disease and bacterial 
vaginosis to increase the risk for adverse pregnancy outcome among 252 women. This 
study suggested that pre-pregnancy counseling should include both oral and vaginal 
examinations to rule out periodontal disease and bacterial Vaginosis. These ultimately 
have an impact on antenatal healthcare, and decrease the risk for adverse pregnancy 
outcome. 
A.Contreras et al (2006) 41 conducted a case control study in pregnant women to know 
whether Periodontitis is associated with pre-eclampsia in Pregnant Women. They 
concluded that chronic periodontal disease and the presence of P. gingivalis, T. 
forsythensis, and E. corrodens were found to be significantly associated with 
preeclampsia in pregnant women.  
Fouzia Tarannum et al (2007) 42 studied the effect of periodontal Therapy on Pregnancy 
Outcome in Women Affected by Periodontitis. They concluded that Non-surgical 
periodontal therapy can reduce the risk for preterm births in mothers who are affected by 
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periodontitis. Additional multicentered, randomized, controlled clinical trials are required 
to confirm this link between periodontitis and preterm low birth weight. 
Pitiphat W et al (2008) 43 conducted a prospective study to know the adverse outcomes 
of maternal periodontitis. Within their limitations of the study, their results suggested that 
periodontitis is an independent risk factor for poor pregnancy outcome among middle-
class women. 
M. V. Vettore et al ( 2008 ) 44 studied the relationship between periodontal disease on 
preterm low birth weight. The results were that the mean periodontal pocket depth was 
significantly higher in non preterm low-birth weight controls than in subjects in the 
preterm low birth weight, preterm and/or low birth weight, and preterm and low-birth 
weight groups. Clinical attachment level measures were not different between all pairs of 
cases and control groups. Groups did not differ with respect to the mean proportions of 
different microbial complexes. The mean counts of Treponema socranskii were lower in 
all case groups compared with the control group. 
Agueda A et al (2008) 45 conducted a prospective cohort study to analyse that  
periodontal disease as a risk factor for adverse pregnancy outcomes . This study found a 
moderate association between periodontitis and PB. Further research is required to 
establish whether periodontitis is a risk factor for PB and/or LBW. 
Bryan S. Michalowicz et al (2009) 46 conducted a study to determine serum 
inflammatory mediators in pregnancy and their changes after periodontal treatment and 
association with pregnancy outcomes. A total of 823 pregnant women were included in 
study. They concluded that non-surgical mechanical periodontal treatment in pregnant 
women, delivered before 21 weeks of gestation, did not reduce systemic (serum) markers 
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of inflammation. In pregnant women with periodontitis, levels of these markers at 13 to 
17 weeks and 29 to 32 weeks of gestation were not associated with infant birth weight or 
a risk for preterm birth. 
Nabet C, Lelong N et al (2010) 47 analyzed the association between maternal 
periodontitis and preterm birth (≥37 weeks’ gestation) according to the causes of preterm 
birth. They concluded that maternal periodontitis is associated with an increased risk of 
induced preterm birth due to pre-eclampsia. 
D. Gandhimadhi, and R. Mythili (2010) 48 conducted study to know about Periodontal 
infection as a risk factor for preterm low birth weight. In this study the cases had 
significantly more attachment loss and probing pocket depth, poor oral hygiene, more 
percentage of sites with attachment loss (Extent) and more mean attachment loss per site 
(Severity) and less Hb than controls. The number of visits for prenatal care and the 
percentage of sites with CAL≥2mm (Extent 2) remained significant when compared to 
other variables. The study indicated that periodontal disease act as  a contributing factor 
for the preterm low birth weight condition .  
Sapna singh et al (2011) 49 did a study to assess whether periodontal disease is 
predictive of premature gestation in an identified population of women at risk for birth 
complications as a consequence of medical factors. This research demonstrated that 
periodontal disease in normal pregnant women is significantly associated with decreased 
infant birth weight, providing new evidence on the relationship between periodontal 
disease and birth weight. Nevertheless, the association between periodontal disease and 
birth weight infant should be further explored in new observational and intervention 
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studies to establish whether it is casual or incidental, and to generalize the findings in 
diverse populations. 
Guimaraes AN et al (2012) 50 aimed to study the very low and low birth weight 
association with maternal periodontitis. They concluded that maternal periodontitis was 
associated with a decrease in mean birth weight, as well as with LBW and VLBW. 
Carrillo-de-Albornoz A et al (2012) 51 studied the gingival changes during pregnancy. 
The results were that PlI was the strongest predictor implicated in the GI throughout 
pregnancy and after delivery. In second and third trimesters the presence of 
Porphyromonas gingivalis significantly found to contribute to the worsening of gingival 
inflammation. When they are compared to the non-pregnant group, significant differences 
were found in TNF-α amounts and concentrations and in the third trimester site-specific 
GI. 
Pourandokht Afshari et al (2013) 52 conducted a study among 180 pregnant women to 
relate the maternal periodontitis and adverse pregnancy outcomes which results indicate 
in development and severity of periodontitis leads to increase  risk of adverse pregnancy 
outcomes. 
Yiqiong Xie et al (2013) 53 conducted a follow up study among 39 females about change 
of periodontal status before and after pregnancy. They concluded that pregnancy may be 
associated with an increased risk of periodontal disease. The association is not different 
between females with Gestational Diabetes Mellitus and females without Gestational 
Diabetes Mellitus during pregnancy. 
Madianos PN et al (2013) 6 evaluated the evidence on potential biological pathways 
underlying the possible association between periodontal disease and adverse pregnancy 
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outcomes (APOs). The evaluation resulted that periodontal pathogens/byproducts may 
reach the placenta and spread to the foetal circulation and amniotic fluid. Their presence 
in the foeto-placental compartment stimulated a foetal immune/inflammatory response, 
which are characterized by the production of IgM antibodies against the pathogens and 
the secretion of increased levels of inflammatory mediators, which in turn may cause 
miscarriage or premature birth. 
Mansi Bansal et al (2013) 54 evaluated the relationship between maternal periodontal 
status and preterm low birth weight. They concluded that many common risk factors for 
PLBW are present along with periodontal diseases (eg, age, socioeconomic status, and 
smoking). However, because the inflammatory mediators that occur in periodontal 
diseases also play an important part in the initiation of labor, there can be a possible 
biologic mechanism that could link the two conditions. 
Mahmoud Edessy et al (2014) 7 evaluated the relationship between periodontal diseases 
and adverse pregnancy outcomes among 300 patients. They found a significant 
relationship between them. 
Pushpalatha Govindaraju et al (2015) 55 conducted a case control study to know the 
relationship between maternal periodontal disease and preterm birth. They concluded that 
an observable relationship was noticed between periodontitis and gestational age, and a 
positive correlation was found with respect to PTB and periodontitis. Further studies 
should be designed to establish periodontal disease as an independent risk factor for 
PTB/preterm low birth weight. 
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C REACTIVE PROTEIN : 
                      CRP is a protein found in plasma involved in the acute phase response. 
CRP was first discovered in 1930 as a protein that could precipitate the C polysaccharide 
derived from the Pneumococcal cell wall (Tillet and Francis 1930). CRP is a interest of 
biomarker in various disease and now a days is a indicator of disease activity . CRP 
consists of five identical, noncovalently associated 23kDa protomers arranged 
symmetrically around a central pore. The term “pentraxins” has been used to describe the 
family of related proteins with this structure. In humans, plasma levels of CRP may rise 
rapidly and markedly, as much as 1000-fold or more, after an acute inflammatory 
stimulus, largely reflecting increased synthesis by hepatocytes. CRP induction is part of a 
larger picture of reorchestration of liver gene expression during inflammatory states, the 
acute phase response, in which synthesis of many plasma proteins is increased 56 . 
Waranuch Pitiphatet al (2005) 57 studied about the C reactive protein in early 
pregnancy and preterm delivery . In summary, they found that CRP levels of more than 8 
mg/liter in early pregnancy were associated with preterm delivery independent of many 
other determinants of preterm delivery. The association was apparent primarily for 
spontaneous preterm delivery. These results were consistent with the hypothesis that 
chronic low-grade inflammation may raise CRP levels and cause preterm delivery. 
Waranuch Pitiphat et al (2007) 58 studied about periodontitis and plasma c reactive 
protein during pregnancy . Their findings suggest that periodontitis may increase CRP 
levels in pregnancy. CRP could potentially mediate the association of periodontitis with 
adverse pregnancy outcomes. 
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Adriana R. Brasil et al (2007) 59 studied to elicit that C-reactive protein as an indicator 
of low intensity inflammation in children and adolescents with and without obesity. The 
objectives is  to determine the levels of high sensitivity C-reactive protein (hsCRP) in 
children/adolescents with and without obesity and their correlation with body mass index 
(BMI) and clinical and laboratory variables. They concluded that the hsCRP 
concentrations increased as BMI increased. The majority of individuals who were not 
overweight exhibited hsCRP concentrations of less than 2 mg/L. 
Anupriya Sharma et al ( 2009 ) 60 evaluated the plasma C-reactive protein levels in 
pregnant women with and without periodontal disease as a comparative study . The 
findings from the study suggested that periodontal disease in pregnant women is 
associated with increased C- reactive protein levels in early pregnancy, incidence of 
preterm delivery is higher in pregnant women with periodontal disease compared to 
healthy controls, periodontal therapy during pregnancy reduces plasma CRP levels and 
there is decrease in incidence of preterm delivery after periodontal therapy. 
Mahdieh Shojaee et al (2013) 61 aimed to study the C - Reactive Protein levels in 
patients with periodontal disease and normal Subjects. The results of this study showed a 
significant correlation between salivary CRP levels and severity of periodontal disease. 
Their study showed that the measurement of salivary CRP can be used as a non-invasive 
and reliable test for the detection and screening of periodontal disease in healthy people. 
Bertha L. Bullen et al (2013) 62 studied  the association between maternal C-reactive 
protein (CRP) and preterm delivery (PTD) pathways, CRP was measured in maternal 
plasma collected at mid-pregnancy. They find that plasma CRP measured at mid-
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pregnancy is associated with sPTD ( spontaneous preterm delivery ) and that the presence 
of HCA( histologic chorioamnionitis )  at delivery accounts for much of this association. 
However, a significant association between CRP and sPTD in the absence of HCA 
remains in higher BMI women, suggesting that CRP in overweight/obese women may 
mark activation of pathways to PTD that are distinct from pathways related to HCA. 
Ajay halder et al (2013) 63 evaluated the predictive significance of C- reactive protein in 
spontaneous preterm delivery. A group of subject with 280 pregnant women , found 
between 12-22 weeks of gestational age attending antenatal clinic were included in a 
prospective cohort and followed through the pregnancy, delivery and early puerperium. 
CRP positivity in early pregnancy is associated with nearly a two fold increased risk of 
preterm delivery. Complications of neonates like preterm birth , low birth weight, 
septicaemia, birth asphyxia and many others are more common in CRP positive mothers. 
Deepika Jayaprakash et al (2014) 64 studied the Effect of periodontal therapy on C-
reactive protein levels in gingival crevicular fluid of patients with gingivitis and chronic 
periodontitis. Within the limitations of this study, they concluded that GCF CRP level 
progressively increases from periodontal health to disease. It can also be stated that there 
is a decrease in GCF CRP levels with periodontal treatment. 
Rajiv Saini (2014) 65 studied whether periodontitis is associated with elevated levels of 
systemic inflammatory biomarker c reactive protein .  This study is outlined to correlate 
salivary c reactive protein level in health, gingivitis, and periodontitis which assess their 
values after completing SRP.  They concluded that a correlation exists between the 
periodontal disease and CRP.  As the periodontal disease regresses the value of CRP 
significantly gets down. SRP was effective in reducing the level of CRP. 
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Stepan Podzimek et al ( 2015) 66 , the aim of this study was to compare and evaluate the 
systemic levels of CRP in the peripheral blood samples of patients found with chronic 
periodontitis and aggressive periodontitis, gingivitis, and gingival recessions and 
compare them with other periodontal clinical parameters. Their study results show that 
CRP levels increase subsequently with the severity of the periodontal disease. The lowest 
CRP levels were found in patients with gingival recessions, increasing in patients with 
gingivitis and patients with chronic periodontitis, with the highest levels found in 
aggressive periodontitis patients. The bleeding on probing index showed much better 
positive correlation with the CRP levels compared to the pocket depth index in both 
periodontitis patient groups, especially in aggressive periodontitis patients. 
P.Savitha et al (2015) 67 compared the salivary CRP level in chronic periodontitis and 
healthy individual. The results of this present study showed that salivary CRP 
concentrations increased in patients with periodontitis comparing to the healthy 
individual and confirming the theory that salivary CRP is increased in inflammatory 
conditions. CRP level in saliva was demonstrable in periodontitis cases.  In normal 
individual the CRP level is 0.1 and less than 0.1 mg/L where as in periodontitis cases, 
60% of the patients have shown 0.2 mg/L. So, the salivary CRP level demonstration is 
definitely having diagnostic value and prognostic value and it can be used as a tool to 
access the improvement in the patient’s condition in periodontal diseases. 
Padmakanth Mannava et al (2016) 68 comparatively elevated the c reactive proteins in 
pregnant women with and without periodontal pathologies . They concluded that casual 
association might exist between the CRP levels and periodontal disease in pregnant 
women and the levels may also get elevated in pregnant women. 
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The study was approved by the Scientific and Ethical Committee review board of Best 
Dental Science College and Hospital, Madurai. The study was carried out from January 
2017 to October 2017. 
STUDY POPULATION 
 The study population were recruited from patients attending outpatient clinics of 
private clinic in Madurai. The study was explained to the concern Gynaecologist 
and Obstetrician in the clinic and permission was obtained to conduct the study. 
 A total of 74 subjects (pregnant women) were included in the study. Out of which 
6 patients were excluded from study, due to loss of follow up. Finally 68 subjects 
were included . 
 All the participants in the study were verbally informed about the nature, risks and 
benefits of the study and a written informed consent was obtained. 
CRITERIA FOR SELECTION OF SUBJECTS 
Inclusion Criteria:  
 Pregnant women with age between 19 years and 40 years. 
 Gestational age  ≤ 32 weeks  
 Singleton pregnancy 1 
Exclusion criteria: 
 Maternal age below 18 and above 40 years . 
 Women with multifoetal pregnancy due to greater risk of preterm birth .1,2  
 Uterine or cervical anomalies. 
 Any previous history of preterm. 
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 Chronic pre gestational conditions that affect pregnancy outcomes, such as pre 
gestational diabetes and chronic hypertension. 1 
 Presence of less than 20 teeth. 
 Alcohol or drug abuse. 1 
ARMAMENTARIUM 
Armamentarium for clinical evaluation: 
 Mouth mirror  
 Explorer 
 Periodontal Williams probe 
 Height chart 
Armamentarium for saliva sample collection: 
 Sample collecting sterile container  
Armamentarium for transport of collected saliva: 
 Ice packs within  thermocole box 
CLINICAL PARAMETERS: 
 Gingival index (GI) 69 
 Probing pocket depth (PPD) 70 
 Clinical attachment loss (CAL) 2 
 Body mass index (BMI) 70 
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Gingival Index (Loe and Silness 1963)  
Table 1: Gingival Index Scores  
Score Cr iter ia  
0 Absence o f inflammat ion/normal gingival  
1 Mild inflammat ion, slight  change in co lour,  slight  edema and 
no bleeding on probing  
2 Moderate inflammat ion, moderate glazing, redness,  edema,  
hypert rophy and bleeding on probing.  
3 Severe inflammat ion, marked redness,  hypert rophy,  
ulcerat ion and tendency for    spontaneous bleeding.  
 
CALCULATION 
 GI Score for the area: Each area (disto-facial, facial, mesio-facial, lingual) is 
assigned a score from 0 to 3 
 GI Score for a tooth: The scores from the four areas of the tooth are added and 
then divided by four. 
 GI score for the individual: The indices for each of the teeth are added and then 
divided by the total number of teeth examined. The scores range from 0 to 3. 
 
 
 
                                                                                     MATERIALS AND METHODS 
 
  28 
 
Table 2: Gingival Index Interpretation 
Gingival scores Condition 
0.1-1.0 Mild Gingivitis 
1.1-2.0 Moderate Gingivitis 
2.1-3.0 Severe Gingivitis 
 
 
Probing pocket depth:  
Determined at six sites (mesio-buccal, mid-buccal, disto-buccal, disto-lingual, mid-
lingual, and mesio-lingual surfaces) of all teeth except for the third molars. Measured 
from the gingival margin to the bottom of the gingival sulcus. 
 
Clinical loss of attachment:  
Determined at six sites (mesio-buccal, mid-buccal, disto-buccal, disto-lingual, mid-
lingual, and mesio-lingual surfaces) of all teeth except for the third molars. Measured 
from the cemento-enamel junction (CEJ) to the bottom of the sulcus. 
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Body mass index:  
TABLE 3 : WHO BMI cut-off points  
   BMI SCORE (kg / m2 )      CRITERIA 
             < 16   Severe underweight  
        16.0-16.9  Moderate underweight  
        17.0-18.49  Mild underweight  
        18.5-24.9  Normal range 
             ≥25  Over weight 
         25-29.9  Pre- obese 
           ≥30.0  obesity 
         30-34.4  obese class I 
         35-39.9  Obese class II 
            ≥40  Obese class III 
 
Overweight and obesity were combined into a single category for analysis because of the 
small number of obese pregnant women. BMI was calculated depending on pre-
pregnancy weight. The values are obtained from the patient through face to face 
interview 1 
 
DEMOGRAPHIC AND HEALTH INFORMATION: All patients responded to a 
demographic questionnaire that included pre-pregnancy weight and height for 
determination of body mass index (BMI), health behaviors. All of these parameters were 
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obtained from a face-to-face interview. Pre-pregnancy weight and height were self-
reported. 1 
 
SALIVARY C REACTIVE PROTEIN COLLECTION AND ESTIMATION: 
The saliva sample is collected before conducting the periodontal examination. After a 
rinse of the mouth with water, saliva was allowed to accumulate in the floor of the mouth 
for approximately 2 minutes and repeatedly expectorated into a sterile sample container 
to collect approximately 5 ml and then the sample is stored in a thermocole ice box till 
they are transported to laboratory. The samples are transported within 24 hours after 
collection.71 The salivary CRP is evaluated by particle-enhanced turbidimetric 
immunoassay (CRP calibrator Euro diagnostic systems).  
 
CLINICAL EXAMINATION: 
Periodontal conditions were assessed by measuring the Gingival index, probing pocket 
depth and clinical loss of attachment. Periodontitis was defined as two or more inter-
proximal sites with CAL ≥4 mm that were not on the same tooth (Page & Eke 2007). 
72,73,1 
 
GROUPING OF THE PATIENT: 
The samples were divided into four groups  
Group A: neither obesity nor Periodontitis 
Group B: Only Obesity 
Group C: Only Periodontitis 
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Group D: Both Obesity and Periodontitis. 
Each group had a sample of 17.  
 
PREGNANCY OUTCOME: 
After the patient delivered, data on the occurrence of PTB were obtained from 
obstetricians from hospital records. PTB was defined as delivery at <37 weeks 1. Infants 
weighing less than 2,500 grams at birth are considered to be low birth weight. 
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   FIGURE 3: ARMAMENTARIUM FOR CLINICAL EVALUATION 
 
                                     
                    
                     
FIGURE 4 : MOUTH MIRROR AND WILLIAMS PROBE 
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FIGURE 5 : ARMAMENTARIUM FOR BODY MASS INDEX EVALUATION-
HEIGHT CHART IN CENTIMETERS 
 
                                                                                                
FIGURE 6 : PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY 
(CRP CALIBRATOR EURO DIAGNOSTIC SYSTEMS) 
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      FIGURE 7:  SALIVARY SAMPLE COLLECTION 
 
                               
FIGURE 8 : INTRA ORAL PHOTOGRAPH 
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      FIGURE 9 :  CLINICAL EXAMINATION OF PROBING POCKET DEPTH 
 
                       
 
  FIGURE 10: PHOTOGRAPH OF DELIVERED INFANT 
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                  The information collected regarding all the selected cases were recorded in a 
master chart. Data analysis was done with the help of computer by using SPSS 16 
software and Sigma stat 3.5 version. Using this software mean, standard deviation and ‘p’ 
value were calculated through One way ANOVA, Chi square test, Pearson correlation 
and  P value of < 0.05 was taken as significant. 
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RESULTS 
The present study was conducted in private hospital to estimate the level of salivary c 
reactive protein in pregnant women with obesity and periodontitis and to identify their 
potential risk for preterm birth. A total of 74 subjects satisfying the selection criteria were 
included in the study. Finally , due to loss in follow up of 6 subjects , 68 subjects were 
finally included in the study. 
                       The clinical parameters including gingival index, probing pocket depth, 
clinical attachment loss, body mass index are evaluated and the salivary sample is 
collected and salivary c reactive protein is estimated. Then patients are followed up and 
post obstetric details are collected. The results thus obtained were tabulated and subjected 
to statistical software SPSS 16 and Sigma stat 3.5 version. 
Comparison of mean age between group A, B, C and D (Table 1 & Graph 1) 
Mean age value of group A, B, C & D was 23.06, 24.88, 26.12 and 24.53 respectively.  
There was no significant difference between the four group values.  p value was 0.188 
which was not significant. 
Comparison of body mass index values (kg/m2) between group A, B, C and D (Table 
2 & Graph 2) 
Mean body mass index values of group A, B, C & D was 21.52, 29.13, 22.49 and 30.37 
respectively. There was highly significant difference between among four groups.  p 
value was <0.001 Significant. 
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Comparison of Mean values of gingival index between the group A, B, C and D 
(Table 3 & Graph 3) 
Mean value of gingival index in group A, B, C & D was 1.15, 1.02, 1.67 & 1.75 
respectively.  There was highly significant difference among the four groups.  p value 
was <0.001 Significant. The mean gingival index values are found to be increased in 
group C and D. 
Comparison of mean probing pocket depth (in mm) values between group A, B, C 
and D (Table 4 and Graph 4) 
Mean value of probing pocket depth in Group A, B, C & D was 2.53, 2.65, 5.41 & 5.29 
respectively. There was highly significant difference among the four groups.  p value was 
<0.001 statistically significant. The probing pocket depth mean values are found to be 
increased in group C and D. 
Comparison of mean clinical attachment (in mm) loss between group A, B, C and D 
(Table 5 and Graph 5) 
Mean clinical attachment loss of group A, B, C & D was 2.59, 2.65, 5.35 & 5.41 
respectively. There was highly significant difference among the four groups.  p value was 
<0.001 statistically significant. The clinical attachment loss was increased in group C and 
D. 
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Mean salivary c reactive protein (mg/L) in group A, B, C and D (Table 6 and Graph 
6) 
Mean value of salivary c reactive protein between groups A, B, C & D was 0.17, 0.09, 
1.32 & 0.60 respectively. The mean value was increased in group C and D, when 
compared to group A and B. 
Correlation between salivary c reactive protein (mg/L) and clinical parameters of 
group A (Table 7) 
Moderate correlation was found between GI and Salivary CRP (mg/L). Good correlation 
(0.710, 0.663) results were found between PPD, CAL and salivary CRP (mg/L).   
Correlation between salivary c reactive protein (mg/L) and clinical parameters of 
group B (Table 8) 
Moderate correlation was found between GI and Salivary CRP. Good correlation was 
(0.660, 0.648) found between PPD, CAL Vs salivary CRP.  Therefore PPD and CAL 
increases simultaneously salivary CRP value was also increased.  
Correlation between Salivary c reactive protein (mg/L) and clinical parameters of 
group C (Table 9) 
Good correlation (0.751, 0.717) was found between GI and PPD and Salivary .Moderate 
correlation (0.470) was found between PPD, CAL and salivary CRP.   
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Correlation between Salivary CRP (mg/L) Vs Other parameters in Group D (Table 
10) 
Good correlation (0.749, 0.691, and 0.725) was found between GI, PPD, CAL Vs 
Salivary CRP.  
Comparison of distribution level of salivary c reactive protein values between 
groups (Table 11 A) and p value comparison among group A to other groups (Table 
11B) 
 In group A, 12 cases are found with value <0.1 salivary CRP, when compare to 
group C only 6 cases are found with <0.1 salivary CRP value. There was 
significant difference between Group A Vs Group C. p value was 0.039, which 
was Significant. 
 In group B, 14 cases are found with <0.1 salivary CRP value, when compare to 
group C only 6 cases are found with <0.1 salivary CRP value .There was 
significant difference between Group A Vs Group C. p value was 0.005, which 
was Significant. 
 In group B, 14 cases are found with <0.1 salivary CRP value , when compare to  
group C only 6 cases are found with  <0.1 salivary CRP value . There was 
significant difference between Group A Vs Group C. p value was 0.005, which 
was significant. 
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Distribution of delivery week of infant among the group A, B, C and D (Table 12 & 
Graph 7) 
Significant difference was found between group A Vs group B and group A Vs group D. 
No significant difference between group B Vs group C and group C Vs group D. 
Distribution of birth weight (kilogram) among the group A, B, C and D (Table 13 & 
Graph 8) 
Significant difference was found between group A Vs group D. No significant difference 
between group A Vs group B   and group A Vs group C was found. 
Distribution of gestational week during sampling among the group A, B, C and D 
(Table 14 & Graph 9) 
It was found that when group A compared to other groups, the p value was 0.670 which 
is not significant. 
Correlation of delivery week, birth weight, gestational week with salivary CRP 
(mg/L) in group A (Table 15)  
In Group A, there was negative moderate correlation between delivery week and birth 
weight to salivary CRP. But low correlation was evident between gestational week and 
salivary CRP. 
 
 
                                                                                                  RESULTS 
 
  42 
 
Correlation of delivery week, birth weight, gestational week with salivary CRP 
(mg/L) in group B (Table 16) 
In group B, there was very low correlation between delivery week and salivary CRP and 
low correlation between birth weight and salivary CRP, and gestational week and 
salivary CRP was 0.309 which is low correlation. 
Correlation of delivery week, birth weight, gestational week with salivary CRP 
(mg/L) in group C (Table 17) 
In group C, there was negative Good correlation between Delivery week and Salivary 
CRP, birth weight and salivary CRP. But very low correlation found between Gestational 
week and Salivary CRP. 
Correlation of delivery week, birth weight, gestational week with salivary CRP 
(mg/L) in group D (Table 18) 
In group D, there was negative good correlation between Delivery week and Salivary 
CRP , Birth weight and salivary CRP.  But very low correlation was found between 
Gestational week and Salivary CRP was 0.132. 
Odd ratio and confidence interval calculation between control group A and group B 
about low birth weight parameter. (Table 19) 
The table explains that the odd ratio =1.00 with C.I =0.0574 to 17.4121. 
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Odd ratio and confidence interval calculation between control group A and group B 
about pre term birth parameter. ( Table 20) 
The table explains that the odd ratio =8.55 with C.I =1.7358 to 42.1700 
Odd ratio and confidence interval calculation between control group A and group C 
about low birth weight parameter. ( Table 21) 
The table explains that the odd ratio = 15.75 with C.I = 1.67 to 148.12. 
Odd ratio and confidence interval calculation between control group A and group C 
about pre term birth parameter. ( Table 22) 
The table explains that the odd ratio = 2.54 with C.I = 0.516 to 12.546 . 
Odd ratio and confidence interval calculation between control group A and group D 
about pre term birth parameter. ( Table 23) 
The table explains that the odd ratio =11.00 with C.I = 1.1931 to 105.1363 
Odd ratio and confidence interval calculation between control group A and group D 
about low birth weight parameter. ( Table 24) 
The table explains that the odd ratio = 8.5556 with C.I = 1.7358 to 42.1700 
Relationship between salivary CRP (mg/L) and delivery weeks (Graph 10) 
The graph explains about the relationship between salivary CRP and delivery weeks. In 
group C and D, when salivary CRP was >0.1 the mean delivery weeks was 35.2 and 35.8 
respectively. 
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Relationship between salivary CRP (mg/L) and birth weight (in kilogram) (Graph 
11) 
The graph explains about the relationship between salivary CRP and birth weight. In 
group C and D, when salivary CRP is >0.1 the mean delivery weeks was 2.64 and 2.69 
respectively. 
Relationship between salivary CRP (mg/L) and gestational week (Graph 12) 
The graph explains about the relationship between salivary CRP and gestational week. In 
group A and B there was low correlation , while in group C and D there was very low 
correlation.  
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Table – 1 Comparison of mean age between groups A, B, C and D. 
 
 
Table – 2 Comparison of body mass index values (kg/m2) between groups A, B, C and D 
 
  
Age Group A Group B Group C Group D 
Mean 23.06 24.88 26.12 24.53 
SD 3.59 4.28 4.4 3.86 
p value 0.188  Not Significant 
BMI Group A Group B Group C Group D 
Mean 21.52 29.13 22.49 30.37 
SD 1.96 3.35 1.63 3.91 
p value < 0.001  Significant 
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Table – 3 Comparison of Mean values of gingival index between the group A, B, C and 
D 
 
 
 
 
 
 
Table – 4 Comparison of mean probing pocket depth (in mm) values between group A, 
B, C and D 
 
 
 
 
 
 
 
 
GI Group A Group B Group C Group D 
Mean 1.15 1.02 1.67 1.75 
SD 0.29 0.20 0.35 0.47 
p value < 0.001  Significant 
PPD Group A Group B Group C Group D 
Mean 2.53 2.65 5.41 5.29 
SD 0.62 0.61 0.51 0.47 
p value < 0.001  Significant 
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Table – 5 Comparison of mean clinical attachment (in mm) loss between group A, B, C 
and D 
 
 
 
 
 
 
Table – 6   Mean salivary c reactive protein (mg/L) in group A, B, C and D 
                                         
   
 
 
CAL Group A Group B Group C Group D 
Mean 2.59 2.65 5.35 5.41 
SD 0.62 0.61 0.70 0.79 
p value < 0.001  Significant 
Salivary 
CRP 
(mg/L) 
Group A Group B Group C Group D 
 
Mean 
 
0.17 
 
0.09 
 
1.32 
 
0.60 
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Table – 7 Correlation between salivary c reactive protein (mg/L) and clinical parameters 
of group A 
 
Table – 8 Correlation between salivary c reactive protein (mg/L) and clinical parameters 
of group B  
Group B Correlation 
coefficient 
Correlation 
Age   Vs Salivary CRP  -0.142 Negative. correlation 
BMI  Vs Salivary CRP  -0.179 Negative. correlation 
GI     Vs Salivary CRP  0.571 Moderate correlation 
PPD  Vs Salivary CRP  0.660 Good correlation 
CAL  Vs Salivary CRP  0.648 Good correlation 
 
 
Group A  Correlation 
coefficient 
Correlation 
Age   Vs   Salivary CRP  -0.239 Negative  correlation 
BMI  Vs   Salivary CRP  -0.193 Negative correlation 
GI     Vs   Salivary CRP  0.474 Moderate correlation 
PPD  Vs   Salivary CRP  0.71 Good correlation 
CAL  Vs   Salivary CRP  0.663 Good correlation 
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Table – 9 Correlation between Salivary c reactive protein (mg/L) and clinical parameters 
of group C 
 
Table – 10 Correlation between Salivary CRP (mg/L) Vs Other parameters in Group D 
Group D Correlation 
coefficient 
Correlation 
Age  Vs Salivary CRP  0.076 Very low correlation 
BMI  Vs Salivary CRP  0.561 Moderate Correlation 
GI     Vs Salivary CRP  0.749 Good correlation 
PPD  Vs Salivary CRP  0.691 Good correlation 
CAL  Vs Salivary CRP  0.86 Good correlation 
 
 
 
Group C Correlation 
coefficient 
Correlation 
Age   Vs Salivary CRP  -0.345 Negative. correlation 
BMI  Vs Salivary CRP  -0.255 Negative. correlation 
GI     Vs Salivary CRP  0.751 Good correlation 
PPD  Vs Salivary CRP  0.47 Moderate correlation 
CAL  Vs Salivary CRP  0.401 Moderate correlation 
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Table – 11 A Comparison of distribution level of salivary c reactive protein values 
between groups 
 
 
Table – 11 B   p value comparison among group A to other groups 
 
 
 
Salivary CRP 
(mg/L) 
Group A Group B Group C Group D 
< 0.1 12 14 6 6 
> 0.1   5 3 11 11 
p value Group  A Vs Group C,D 0.039  Significant 
 Group B Vs Group C 0.005  Significant 
 Group B Vs Group D 0.005 Significant 
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TABLE -12 Distribution of delivery week of infant among the group A, B, C and D 
Delivery week Group A Group B Group C Group D 
> 37   14 6 8 6 
 33 - 37   3 10 6 10 
 < 32  0 1 3 1 
p value Group  A 
Vs 
0.019 Sig 0.06 NS 0.019  Sig 
0.034  Significant 
 
TABLE – 13 Distribution of birth weight (kilogram) among the group A, B, C and D 
 
BIRTH WEIGHT 
 
Group A 
 
Group B 
 
Group C 
 
Group D 
< 2.5   1 1 6 7 
> 2.5  16 16 11 10 
p value Group  A Vs 1.0  NS 0.085 NS 0.043  NS 
p value 0.015  Significant 
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Table- 14 Distribution of gestational week during sampling among the group A, B, C and 
D 
 
 
 
 
 
 
 
Gestational week at 
sampling 
Group A Group B Group C Group D 
< 20   12 12 12 8 
 21 – 28   3 3 4 7 
> 28   2 2 1 2 
  Group  A Vs 1.0   NS 0.788  NS      0.301  NS 
p value 0.670 Not Significant 
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Table – 15 Correlation of delivery week, birth weight, gestational week with salivary 
CRP (mg/L) in group A 
 
 
 
 
 
 
 
Group A Correlation 
coefficient 
Correlation 
Delivery week  Vs 
Salivary CRP  
-0.557 Negative Moderate   Correlation 
Birth weight  Vs Salivary 
CRP  
-0.471 Negative Moderate Correlation 
Gestational Week Vs 
Salivary CRP  
0.258 Low correlation 
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Table – 16 Correlation of delivery week, birth weight, gestational week with salivary 
CRP (mg/L) in group B 
 
 
 
Group B Correlation 
coefficient 
Correlation 
Delivery weeks  Vs Salivary 
CRP  
0.044 Very low correlation 
Birth weight  Vs Salivary CRP  0.35 Low correlation 
Gestational Weeks at 
sampling     Vs Salivary CRP  
0.309 Low correlation 
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Table -17 Correlation of delivery week, birth weight, gestational week with salivary 
CRP (mg/L) in group C 
Group C Correlation coefficient Correlation 
Delivery weeks  Vs Salivary 
CRP  
-0.818 Negative. Good 
correlation 
Birth weight  Vs Salivary CRP  -0.725 Negative. Good 
correlation 
Gestational Weeks at sampling     
Vs Salivary CRP  
0.017 Very Low correlation 
Table -18 Correlation of delivery week, birth weight, gestational week with salivary 
CRP (mg/L) in group A 
Group D Correlation coefficient Correlation 
Delivery weeks  Vs Salivary 
CRP  
-0.706 Negative Good correlation 
Birth weight  Vs Salivary CRP  -0.663 Negative Good correlation 
Gestational Weeks at sampling     
Vs Salivary CRP  
0.132 Very Low correlation 
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 Table 19: Odd ratio and confidence interval calculation between control group A 
and group B about low birth weight parameter. 
  
Table 20: Odd ratio and confidence interval calculation between control group A 
and group B about pre term birth parameter. 
 
  
 
GROUP LBW-
PRESENT  
LBW-
ABSENT 
 
GROUP B 
 
       1 
 
       16 
 
GROUP A 
 
       1 
 
      16 
Odds ratio  1.0000 
95 % CI: 0.0574 to 17.4121 
z statistic 0.000 
Significance level P = 1.0000 
GROUP PTB-
PRESENT 
PTB-
ABSENT 
 
GROUP B 
 
      11 
 
        6 
 
GROUP A 
 
       3 
 
       14 
Odds ratio  8.5556 
95 % CI: 1.7358 to 42.1700 
z statistic 2.638 
Significance level P = 0.0083 
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Table 21: Odd ratio and confidence interval calculation between control group A 
and group C about  low birth weight parameter. 
 
Table 22: Odd ratio and confidence interval calculation between control group A 
and group C about  pre term birth parameter. 
 
 
 
GROUP LBW-
PRESENT  
LBW-
ABSENT 
 
GROUP C 
 
      9 
 
       8 
 
GROUP A 
 
       1 
 
      16 
Odds ratio                  15.7500 
95 % CI:                     1.674 to148.124 
z statistic                     2.411 
Significance level        0.0159 
Odds ratio                 2.5455 
95 % CI:                   0.516 to 12.546 
z statistic                   1.148 
Significance level      0.2510 
GROUP PTB-
PRESENT 
PTB-
ABSENT 
GROUP 
C 
6 11 
GROUP 
A 
3 14 
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Table 23: Odd ratio and confidence interval calculation between control group A 
and group D about low birth weight parameter 
 
Table 24: Odd ratio and confidence interval calculation between control group A and 
group D about pre term birth parameter. 
 
 
 
GROUP 
LBW-
PRESENT  
LBW-
ABSENT 
 
 GROUP  D 
 
        7 
 
      10 
 
 GROUP A 
 
         1 
 
       16 
Odds ratio  11.2000 
95 % CI: 1.1931 to 105.1363 
z statistic 2.115 
Significance level P = 0.0345 
GROUP PTB-
PRESENT 
PTB-
ABSENT 
 
GROUP D 
 
       11 
 
         6 
 
GROUP A 
 
         3 
 
         14 
Odds ratio  8.5556 
95 % CI: 1.7358 to 42.1700 
z statistic 2.638 
Significance level P = 0.0083 
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Graph -1 Comparison of mean age between group A, B, C and D. 
 
Graph -2 Comparisons of body mass index values (kg/m2) between group A, B, C and D 
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Graph -3 Comparison of Mean values of gingival index between the group A, B, C and 
D 
 
Graph – 4 Comparison of mean probing pocket depth (in mm) values between group A, 
B, C and D    
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Graph-5 Comparison of mean clinical attachment (in mm) loss between group A, B, C 
and D 
 
 
Graph-6 Mean salivary c reactive protein in group A, B, C and D 
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Graph – 7 Distribution of delivery week of infant among the group A, B, C and D 
 
 
Graph -8 Distribution of birth weight (kilogram) among the group A, B, C and D 
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Graph – 9 Distribution of gestational week during sampling among the group A, B, C 
and D 
 
Graph – 10 Relationship between salivary CRP (mg/L) and delivery weeks. 
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Graph -11 Relationship between salivary CRP (mg/L) and birth weight. 
 
 
Graph – 12 Relationship between salivary CRP (mg/L) and gestational week 
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DISCUSSION  
                      A woman who lack their periodontal care during the initial period of their 
life, was the most important significant predictor of lacking their care during pregnancy 
period. 74 Changes in the oral cavity can occur with pregnancy, which include alterations 
in both the hard and soft tissues structures. 75 The periodontal changes such as pocket 
formation, increased tooth mobility and loss of attachment may lead to decrease in oral 
health status and leads to loss of teeth. 76,77 A multi-state study had concluded that, 
besides neglecting medical care during pregnancy, most of the expectant females of all 
ages do not seek for the dental care, even if the 50 percent of them have a dental problem. 
78   Saliva is a unique biological fluid, which has an important role in the maintaining of 
oral physiology. It plays the major role in the process of oral and general health 
maintenance (Humphrey 2001) 79. According to recent data, it mirrors general health 
condition which can reflect various systemic changes, which occurs in the body. 
                    Serum CRP concentration usually increases in the case of systemic 
inflammatory conditions like systemic infection and inflammation. CRP was the most 
commonly used acute phase protein in the clinical practice. Few studies evaluated about 
the CRP levels in oral cavity. A study evaluated among 45 adults in whole saliva to 
detect the level of C reactive protein. The concentrations range from 0 to 472 pg/ml were 
found in samples. The level was higher in patients with gingivitis, moderate and severe 
periodontitis (Pederson, 1995) 80. 
                    The aim of the study was to estimate the level of salivary c reactive protein 
in pregnant women with obesity and periodontitis and to identify their potential risk for 
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preterm birth. In this study, there were 4 groups based on obesity and periodontitis. The 
obesity was calculated using body mass index and periodontitis was considered when 
subject had 2 or more interproximal sites with CAL≥ 4mm that were not on the same 
tooth. (M4, M5, 1). 
                    The mean body mass index of the sample were found to be increased in 
group B and D, which were 29.13 and 30.37 respectively , these results  found to be in 
correlation with study done by Naidoo T et al 2012 81 . When the mean value of GI, 
PPD, CAL were compared. The values were increased in group C and D when compared 
to other groups. The values were 1.67 and 1.75, 5.41 and 5.29, 5.35 and 5.41 
respectively. The mean salivary c reactive protein level in group A, B, C, and D were 
0.17, 0.09, 1.32 and 0.60 respectively. The mean level of salivary c reactive protein were 
comparatively increased in group with periodontitis, both periodontitis and obesity when 
compared to other. The increased mean level of salivary c reactive protein found 
correlated with the study done by P.Savitha and R.Shasmitha in 2015.(r37). 
                    The correlation between body mass index to salivary c reactive protein was 
correlated in all four groups, while moderate correlation was found in group D. The 
moderate and good correlation between gingival index and salivary CRP was seen in 
group A and B and in group C and D respectively. The PPD and CAL was found to have 
good correlation with salivary C reactive protein in group A, B and D and moderately 
correlated in group C.  
                    Pre term birth was defined as delivery at <37 weeks of gestation 1. In group 
A, 3 subject had preterm birth, while in group B, C and D 11, 9, and 11 preterm birth 
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were recorded respectively. Statistically significance were found between group A when 
compared B,C and D. In this study, subjects with periodontitis had increased risk of 
preterm birth, the similar results were found in the study done by Agueda et al (2008) 3, 
Macedo et al (2014) 82 and Pitiphat W et al (2008) 48.  
                   Infants weighing less than 2,500 grams at birth are considered to be low birth 
weight. In group D, 7 subjects gave birth to infant with weight ≤2.5kg which was 
considered as low term birth, found to be statistically significant when compared to group 
A respectively. Offenbacher S et al (2001)39 ,  Pederson, E (1995)80 , Ide et al (2013) 83 
found that patient with periodontitis gave delivery  to low birth weight infants which was 
found to be correlating with results of the present study. When infant weight and salivary 
CRP are correlated, in group C and D they found to have negative good correlation ie., 
when salivary c reactive  protein level increased there were increased risk for preterm 
birth ( decreased delivery weeks). 
                      The association was stronger in obesity patient to get preterm birth with 
odds ratio=8.556 and C.I = 1.7358 to 42.1700. The association was stronger in group C to 
get low birth weight infants and preterm birth with odds ratio= 15.75 , C.I = 1.67 to 
148.12 and odds ratio= 2.54 , C.I = 0.516 to 12.546  respectively. The association was 
also stronger in group D patients to get preterm birth and low birth weight with odds 
ratio=11.2000,C.I= 1.1931 to 105.1363 and odds ratio=8.5556, C.I= 1.7358 to 42.1700 
respectively. The odds ratio of more than one value suggest , there is strong association 
between them. 2 ( C.I- confidence interval ) 
                      Periodontal status may be associated with PTB and PE (Boggess et al. 
2003) 84 . The association between maternal periodontal health and adverse pregnancy 
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outcomes has been confirmed out in many studies. Our findings were consistent with the 
results from some of the previous studies conducted. Offenbacher 1991 suggested that 
the mechanism feasibly between the periodontal inflammation and the poor foetal growth 
includes the translocation of periodontal pathogens, inflammatory mediators, and 
bacterial products such as lipopolysaccharides to the fetoplacental unit.  
                      Obesity is also one of the largest attributable and potentially modifiable risk 
factors for PE and PTB (Torloni et al. 2009) 85. Cnattingius et al. (2013) 86  reported 
that maternal overweight and obesity were associated for an increased risk for PTB. 
Maternal obesity is associated with inflammatory up-regulation through increased 
production of adipokines and enhanced systemic secretion of proinflammatory cytokines 
(Ramsay et al. 2002) 87 . Specific complications of pregnancy that occur in obesity can 
also lead to PTB (Parker et al. 2014) 88 ; the potential mediators of pre-pregnancy 
obesity and PTB are hypertensive disorders of pregnancy, chorioamnionitis, gestational 
diabetes, and other common conditions among obese women . However, Ehrenberg et 
al. (2009) 89 found opposing results between maternal obesity and spontaneous PTB, and 
explained that the results may be due to chance caused by the small sample size or their 
definition of preterm birth. We also found that there was low correlation  between obesity 
subjects, which was consistent with above study results. Considering the abundance of 
evidence supporting the association among obesity, periodontitis, and PTB, it can be 
inferred that obesity and periodontitis before or during pregnancy have synergistic effects 
on PTB. There is a link between obesity and periodontal disease, but the risk factors that 
aggravate these diseases should be clarified to clarify the meaning of this association. 
Despite the growing volume of data generated by human studies and the experimental 
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animal models, the clinical application of this information to the practice of dentistry 
needs to be carefully delineated. Although most of the studies to date indicate a positive 
correlation, it is still too early to attribute a cause and effect. 
                          In an overview of periodontitis and obesity, whether one condition stands 
as a risk factor for another or whether one disease causes another has yet to be elucidated. 
What has emerged from the literature, however, is that an association between obesity 
and periodontitis exists and that association most likely lies in the commonality of their 
inflammatory pathways. The relentless release of pro-inflammatory cytokines into the 
systemic circulation from adipose tissue in obese individuals provides a systemic 
inflammatory overload. These cytokines may directly injure the periodontal tissues or 
reduce the vascular blood flow to the periodontal tissues. Periodontitis, itself an 
inflammatory disease, induces its own set of cytokines both locally and systemically in 
response to bacterial pathogens and endotoxins and thus adds to the level of circulating 
proinflammatory mediators. As such, periodontitis increases the systemic level of 
inflammation and thus may contribute to systemic inflammatory diseases and a 
bidirectional link. Long-term prospective studies are needed to further elucidate specific 
cause and effect relationships between obesity and periodontitis as well as to the wider 
body of other chronic inflammatory diseases.  
                    The limitation of the study was those patients were requited from a single 
clinic. The study was only observational type. The patient did not undergo any 
periodontal treatment measures. The pre-pregnancy weight details of the patient was 
obtained only face to face interview, as there can be sometime a subjective variance. 
Overweight and obesity were combined into a single category for analysis because of the 
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small number of obese pregnant women. Within the limitations of the study, it is shown 
that the obesity and periodontitis act synergistically risk factor for preterm birth. In 
future, the studies should be directed with treatment measures. The salivary C reactive 
protein act as a reliable method to estimate the level of inflammation, which is a non 
invasive and simple method. Anticipatory guidance should be given to women with 
obesity to maintain proper periodontal health status to avoid a risk factor for preterm birth 
in future. The awareness about periodontal health maintenance and risk poor oral hygiene 
status should be increased among the public. 
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                                         SUMMARY AND CONCLUSION               
            The present study was conducted to estimate the level of salivary C reactive 
protein in pregnant women with obesity and periodontitis and to find their risk for 
preterm birth. A total of 74 pregnant women were included in the study. Depending on 
inclusion and exclusion criteria the sample was divided into 4 groups equally based on 
obesity and periodontitis criteria. Due to loss of follow up 6 patients were excluded from 
the study. 
            The clinical parameters like Gingival index, PPD, CAL, and BMI were recorded. 
Salivary c reactive protein was analyzed using particle enhanced turbidimetric 
immunoassay. The patient were followed and observed for post obstetrics details. 
 From the results of the study, we arrive at the following conclusions: 
 In patients with only obesity, association was found between pre term birth and 
obesity  
 In patients with only periodontitis, association was found between both preterm 
birth and low birth weight of the infants. 
 In patient with both obesity and periodontitis, association was found between 
them and preterm birth and low birth weight. 
 Obesity and periodontitis are strongly associated and act as a risk for preterm 
birth of low birth weight. 
 Salivary C reactive protein acts as a reliable non invasive way to evaluate the 
inflammatory levels. 
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 The results of this study indicate that pregnant women with both obesity and 
periodontitis are signiﬁcantly more likely to have PTB than pregnant women in 
control group. Our results support that maternal obesity must be controlled and 
managed prior to pregnancy; in particular, obese pregnant women must manage 
and maintain better periodontal health than normal weight pregnant women in 
order to reduce PTB with LBW. 
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ANNEXURE 2 
INFORMED CONSENT FORM 
 
  
                    Name: Mrs                                                          REF.No: 
                Address:                          SEX : Female 
                AGE:      Years 
 
 
 
I …………………………………….., exercising my free power of choice, hereby give 
my consent to be included as a participant in the study . 
 
I agree to the following; 
1. I have been informed to my satisfaction about the purpose of the study 
2. I understand that the study involves questions which may sometimes be personal 
3. I agree to co -operate fully for complete examination 
4. I agree to report to my doctor for a regular follow up and when required for the 
research  
5. I hereby give permission to use my medical records for research purpose. I have 
been told that the investigating doctor and the institution will keep my identity 
confidential 
6. I understand that I have rights to withdraw myself from the study and also that the 
investigator has the right to exclude me from the research at any point of time. 
INVESTIGATOR:                                                                                               
SIGNATURE OF THE PARTICIPANT:                        Signature/Thumb impression  
                                           
                                                                                                    ANNEXURE 
 
                                 ANNEXURE 3    
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                                             ANNEXURE 4 
 
BEST DENTAL SCIENCE COLLEGE, MADURAI 
TAMILNADU DR.MGR MEDICAL UNIVERSITY 
DEPARTMENT OF PERIODONTOLOGY 
 
                              MAIN DISSERTATION PROFORMA 
                                     PATIENT INFORMATION 
 
REFERENCE NUMBER:                                     S.NO:                                       DATE: 
 
NAME OF THE PATIENT:                                 AGE:           SEX:                     
ADDRESS: 
 
 CONTACT NUMBER: 
 
OBSTETRICS INFORMATION  
 
GESTATIONAL AGE: 
 
AGE AT FIRST DELIVERY: 
 
PARITY: 
              NONE: 
              ONE OR MORE: 
                                                                                                    ANNEXURE 
 
 
HISTORY OF ABORTION:     YES / NO 
 
HISTORY OF PRETERM BIRTH:  YES / NO 
 
HISTORY OF SCALING DONE BEFORE ONE YEAR: YES / NO 
SMOKING BEFORE PREGNANCY:  YES / NO 
 
WEEKLY DRINKING BEFORE PREGNANCY:  NO / LESS THAN 1 / ONCE OR 
MORE  
 
WEEKLY EXERCISE BEFORE PREGNANCY   : NO / 1-2 TIMES / MORE THAN 3 
TIMES 
 
WEIGHT BEFORE PREGNANCY:     WEIGHT AT PRESENT: 
 
HEIGHT: 
 
FAMILY HISTORY: 
 
MEDICAL HISTORY: 
 
SYSTEMIC DISEASE: 
 
SYSTEMIC MEDICATION: 
 
                                                                                                    ANNEXURE 
 
                                       GINGIVAL INDEX – LOE AND SILNESS 1963 
17        16         15       14          13       12         11        21        22       23       24          25        26         27 
47       46       45        44         43      42         41       31       32      33         34      35         36      37 
 
CALCULATION : 
 
IMPRESSION : 
 
                                                   PROBING POCKET DEPTH 
 
              
              
 17       16        15      14        13      12       11      21        22       23       24      25        26       27 
47       46        45      44        43      42       41      31        32       33       34      35        36       37 
              
              
 
IMPRESSION : 
                                            
 
                                          
              
                                          
              
B 
P 
B 
L 
B 
P 
L 
B 
                                                                                                    ANNEXURE 
 
                                       CLINICAL ATTACHMENT LOSS 
 
 
              
                  
 17       16        15      14        13      12       11      21        22       23       24      25        26       27 
 47       46        45      44        43      42       41      31        32       33       34      35        36       37 
              
              
 
 
 
IMPRESSION : 
 
 
 
PATIENT HAS PERIODONTITIS ACCORDING TO CRITERIA : YES / NO 
 
BMI CALCULATION:  WEIGHT IN KILOGRAM 
                                           (HEIGHT IN METERS)2 
IMPRESSION FROM BMI: 
 
 
 
 
 
B 
P 
L 
B 
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PATIENT INCLUDED UNDER GROUP: 
 
GROUP A:  NEITHER PERIODONTITIS NOR OBESITY 
 
GROUP B:  ONLY OBESITY  
 
GROUP C:  ONLY PERIODONTITIS  
 
GROUP D:  BOTH OBESITY AND PERIODONTITIS  
 
SALIVARY C- REACTIVE PROTEIN REPORT: 
 
POST PARTUM DETAILS  
 
DELIVERY OF INFANT :                        WEEKS                                        
 
PRETERM BIRTH:  YES / NO 
 
DATE OF DELIVERY: 
 
WEIGHT OF INFANT: 
 
 
 
SIGNATURE OF THE INVESTIGATOR                        SIGNATURE OF THE GUIDE 
                                                                                                    ANNEXURE 
 
                                                      MASTER CHART                 
                                                                 GROUP A                                                                
                                                                    GROUP B 
REF.NO AGE   BMI    GI PPD CAL SALIVARY 
CRP 
d.weeks weight g.weeks 
B1 28 25.8 1.15 3 3 0.1 38 3 7 
B2 28 25.72 1.41 3 3 <0.1 39 2.7 16 
B3 20 25.8 0.74 3 3 <0.1 40 3 20 
B4 24 27.39 0.82 2 2 <0.1 36 2.6 8 
B5 26 25.33 0.9 2 2 <0.1 40 2.95 8 
B6 22 28.14 1.1 3 2 0.1 37 3.2 14 
B7 20 34.89 1.13 2 2 <0.1 34 3 7 
B8 24 30.46 1.12 2 3 <0.1 36 3.2 20 
B9 29 28.06 0.79 2 2 <0.1 36 2.9 7 
B10 30 31.73 0.91 3 3 <0.1 36 3.2 32 
B11 35 34.13 0.98 3 3 <0.1 32 2.5 28 
B12 28 32.79 0.84 3 3 <0.1 37 3 9 
B13 23 27.83 1.36 4 4 0.4 37 3.4 28 
B14 20 33.72 1.09 2 2 <0.1 35 3 32 
B15 24 27.04 0.84 3 3 <0.1 37 3.44 24 
B16 20 31.2 1.18 3 3 <0.1 40 3.4 12 
B17 22 25.23 1.04 2 2 <0.1 40 3.4 8 
 
          
REF.NO AGE   BMI    GI PPD CAL 
SALIVARY 
CRP d.weeks weight g.weeks 
      A1 33 22 0.85 2 2 <0.1 38 2.9 20 
A2 22 19.7 1.65 3 3 <0.1 37 2.8 24 
A3 19 20.88 1.14 2 3 <0.1 40 3.4 8 
A4 24 23.45 0.81 2 2 <0.1 40 2.7 20 
A5 21 22.26 0.93 2 2 <0.1 38 2.8 18 
A6 28 22.1 1.07 2 2 <0.1 40 3 16 
A7 27 19.97 1.03 3 3 <0.1 39 3.4 32 
A8 21 20.2 1 3 3 0.1 40 2.8 18 
A9 20 20.45 1.75 4 4 1.1 36 2.45 24 
A10 20 24.8 1.15 3 3 0.1 39 3.3 20 
A11 24 24 0.77 2 2 <0.1 39 3 8 
A12 20 18.17 1.05 2 2 <0.1 40 3.2 24 
A13 20 22.31 1.16 2 3 <0.1 38 2.9 12 
A14 24 23.62 1.3 3 2 0.1 37 2.6 12 
A15 22 18.32 1.09 3 3 <0.1 40 3.2 8 
A16 23 20.82 1.66 3 3 0.2 39 2.6 30 
A17 24 23.24 1.13 2 2 <0.1 39 3.4 12 
                                                                                                    ANNEXURE 
 
                                                                               GROUP C 
 
                                                                               GROUP D 
REF.NO AGE   BMI    GI PPD CAL SALIVARY 
CRP 
D.weeks weight  g.weeks 
D1 21 25.55 1.38 5 5 0.3 36 2.4 12 
D2 31 31.11 1.45 5 5 0.2 36 2.5 18 
D3 26 29.13 1.53 5 5 0.1 37 3.2 21 
D4 27 36.2 2.8 6 8 4.8 32 2.2 24 
     D5 22 31.34 1.464 5 5 <0.1 39 3.2 12 
D6 24 32.65 2.7 6 6 1.5 35 2.5 20 
D7 25 25.1 1.79 5 5 <0.1 40 3.4 12 
D8 20 30.53 2.12 6 5 0.8 35 2.5 32 
D9 24 29.5 1.93 5 5 0.1 40 3.2 24 
D10 28 32.1915 1.41 5 5 0.1 38 3.2 24 
D11 21 27.77 1.9 5 6 <0.1 40 3.2 28 
D12 22 25.51 1.43 5 5 <0.1 39 3.5 28 
D13 25 27.27 1.18 5 6 <0.1 36 3.2 20 
D14 34 29.75 1.68 5 5 <0.1 36 3.2 12 
D15 25 28.571 1.36 6 5 0.9 35 2.5 12 
D16 22 30.6 2.2 6 6 1.1 34 2.4 28 
D17 20 35.714 1.41 5 5 0.1 36 2.8 31 
 
REF.NO AGE   BMI    GI PPD 
 
SALIVARY 
CRP 
d.weeks weight g.weeks 
C1 27 22.37 1.52 5 5 <0.1 38 3.2 12 
C2 30 24.79 1.5 6 6 0.1 39 3.2 17 
C3 25 23.71 1.32 5 5 <0.1 37 3 32 
C4 29 24.16 1.64 5 5 <0.1 39 3 20 
C5 24 20.44 1.42 6 6 0.2 36 2.5 24 
C6 27 21.003 1.58 5 5 <0.1 40 2.6 8 
C7 26 23.922 2.3 6 6 6.8 32 2.4 17 
C8 22 22.47 1.3 5 4 <0.1 40 2.7 12 
C9 27 20.44 2.2 6 6 0.6 36 2.6 24 
C10 28 24 1.36 5 5 0.1 39 3.2 16 
C11 34 20.08 1.92 5 6 0.3 37 2.6 24 
C12 25 24 1.9 6 6 0.6 35 2.5 8 
C13 21 24.21 1.44 5 4 <0.1 38 3 28 
C14 19 22.31 1.49 5 5 0.8 34 2.5 8 
C15 35 22.66 1.49 5 5 0.1 39 3.2 20 
C16 20 20 2.4 6 6 11.2 28 1.8 20 
C17 25 21.77 1.55 6 6 1.2 32 2.4 16 
CAL 
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